These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9109046)

  • 1. Pharmacokinetics and pharmacodynamics of pirmenol enantiomers in coronary artery ligated dogs.
    Janiczek N; Smith DE; Chang T; Ventura A; Mertz TE
    J Pharm Sci; 1997 Apr; 86(4):443-9. PubMed ID: 9109046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of pirmenol enantiomers and pharmacodynamics of pirmenol racemate in patients with premature ventricular contractions.
    Janiczek N; Smith DE; Chang T; Sedman AJ; Stringer KA
    J Clin Pharmacol; 1997 Jun; 37(6):502-13. PubMed ID: 9208357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective high-performance liquid chromatographic assay for pirmenol enantiomers in dog plasma.
    Janiczek N; Bockbrader HN; Chang T; Amidon GL; Smith DE
    J Chromatogr; 1991 Nov; 571(1-2):179-87. PubMed ID: 1810946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics and pharmacokinetics of oral pirmenol.
    Ellenbogen KA; Roark SF; Sintetos AL; Smith MS; McCarthy EA; Smith WM; Kates RE; Pritchett EL
    Clin Pharmacol Ther; 1987 Oct; 42(4):405-10. PubMed ID: 3665339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
    Mertz TE; Kaplan HR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology and pharmacokinetics of pirmenol.
    Reiter MJ
    Angiology; 1988 Mar; 39(3 Pt 2):293-8. PubMed ID: 3281518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pirmenol: preclinical pharmacology.
    Kaplan HR; Mertz TE; Steffe TJ
    Angiology; 1988 Mar; 39(3 Pt 2):281-92. PubMed ID: 3281517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pirmenol hydrochloride (CI-845): antiarrhythmic profile in coronary artery ligated conscious dogs.
    Mertz TE; Steffe TJ
    J Cardiovasc Pharmacol; 1980; 2(5):527-41. PubMed ID: 6157947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and pharmacokinetics of oral pirmenol, a new antiarrhythmic drug.
    Garg DC; Jallad NS; Singh S; Ng KF; Weidler DJ
    J Clin Pharmacol; 1988 Sep; 28(9):812-7. PubMed ID: 2466056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical pharmacology of pirmenol.
    Kaplan HR; Mertz TE; Steffe TJ
    Am J Cardiol; 1987 Jun; 59(16):2H-9H. PubMed ID: 3591710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects of pirmenol, its metabolite 2, and enantiomers, on cardiac Purkinje fibers.
    Lee JH; Rosen MR
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):416-22. PubMed ID: 7504132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective pharmacokinetics and pharmacodynamics of disopyramide and its metabolite in rabbits.
    Horikawa M; Yasumuro M; Kanno M; Hanada K; Hashiguchi M; Ogata H
    J Pharm Pharmacol; 2001 Dec; 53(12):1621-8. PubMed ID: 11804392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ibutilide and its enantiomers in dogs.
    Hsu CY; Walters RR
    Chirality; 1996; 8(1):18-23. PubMed ID: 8845277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic plasma concentrations of pirmenol on canine ventricular arrhythmias.
    Hashimoto K; Watanabe K; Sugiyama A
    Jpn J Pharmacol; 1988 Oct; 48(2):273-82. PubMed ID: 3210450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of the antiarrhythmic drug pirmenol.
    Phillips HR; Stack RS; Davis DD; Morris KG; Lee KL; Shand DG; Pritchett EL
    Clin Pharmacol Ther; 1982 Aug; 32(2):235-9. PubMed ID: 7094511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of pirmenol in young and elderly subjects.
    Ferry DG; Campbell AJ; Bland R; Beasley M; Gazeley L; Edwards IR
    Eur J Clin Pharmacol; 1992; 43(4):437-9. PubMed ID: 1451728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical and clinical pharmacokinetics of pirmenol.
    Chang T
    Am J Cardiol; 1987 Jun; 59(16):15H-19H. PubMed ID: 2438922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced pirmenol elimination by rifampin.
    Stringer KA; Cetnarowski AB; Goldfarb A; Lebsack ME; Chang T; Sedman AJ
    J Clin Pharmacol; 1988 Dec; 28(12):1094-7. PubMed ID: 3243925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute haemodynamic effects of the antiarrhythmic agent pirmenol in cardiac patients: a comparison with lidocaine.
    Nieminen MS; Toivonen LK; Manninen V; Frick MH
    Eur Heart J; 1986 Feb; 7(2):150-7. PubMed ID: 3516703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients.
    Aso R; Ohashi K; Katoh T; Ogata H
    Int J Clin Pharmacol Res; 2001; 21(3-4):137-46. PubMed ID: 12067143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.